REFERENCES

US

 
Stanford University, Medical Center, Palo Alto, CA
4000 Pro-X
University of Florida, Gainesville, FL 4000 Pro-X
Barbara Davis Center for Childhood Diabetes, Aurora, CO
4000 Pro-X
AMGEN Inc., Cambridge, MA 5000 Pro-X i
Purdue University, West Laffayette, IN
5000 Pro-S
UTSW, Dallas, TX
5000 Pro
BAYER, San Francisco Bay, CA 5000 Pro-X
Emory University, Atlanta, GA
5000 Pro
MedImmune LLC, Gaithersburg, MD 5000-E
Texas Tech University, Health Sciences Center, Lubbock, TX
5000-E
Scripps Florida, Department of Infectology, Jupiter, FL 5000-E beta
Crucell Biologics Inc., San Diego, CA 6000-F alpha
Midwestern University, Downers Grove, IL
6000-F-Z beta
OncoMed Pharmaceuticals, Redwood City, CA
6000-E beta
Johns Hopkins University School of Medicine, Baltimore, MD
4000-E
IOMAI, Gathersburg, MD 4000
Fred Hutchinson Cancer Research Center, Seattle, WA 3000 + 5000-V
Dynavax Technologies, Berkeley, CA 3000
University of Washington, Clinical Center, Seattle, WA 3000
University of Virginia, Charlottesville, VA 3000 + 4000
GenPath Pharmaceuticals Inc., Baltimore, Cambridge, MA 3000
Georgia State University, Atlanta, GA
5000-E beta
    

CANADA

Univ.of British Columbia, Research Insitute, Vancouver, BCer,
3000 + 4000 Pro-X
University of Alberta, Medical Research Center, Edmonton, AB
4000 Pro-F/-S
McMasters University, Hamilton, ON
5000 Pro-S
Univ. of British Columbia, Life Sciences Centre, Vancouver, BC
5000 -V
   

CHINA

Academy of military medical sciences, Beijing 4000 Pro-X
CDC Peijing, Center of AIDS 4000 Pro-X
National Institute for the control of pharmaceutical
and biological products
, Beijing
4000 Pro-X
YouAn Hospital, Capital Medical University, Beijing 4000
Shanghai Center of Disease Control and Prevention 4000 Pro-X
Guangzhou Institute of Biomedicine and Health,
Chinese Academy of Sciences
4000 Pro-X
Second military Medical University, Shanghai 4000 Pro-X
Donghu Hospital, Shenzhen HIV
Institute for viral disease control and prevetion, Beijing HIV
   

UK

King’s College London 3000 + 5000-E
University of Aberdeen 3000 Pro
University of Bristol, Henry Wellcome Laboratories
for Integrative Neuroscience and Endocrinology
4000 Pro-S
BSI Papworth-Hospital, Cambridge 5000 Pro-Xi
Queen Mary School of Medicine, London 5000 Pro-Xi
MRC Prion Unit, Institute of Neurology, London 5000-E beta
Leicester Royal Infirmary 6000 –F beta
University of Birmingham, Institute of Biomedical Research 6000-F gamma
   

GERMANY

Primate Center Göttingen 3000
University Münster 3000
University Kiel, Immunology 3000
Bernhard Nocht Institute Of Tropical, Hamburg 2000
National Animal Health Reseach Institute, Greifswald-Insel Riems 3000
DKFZ, Mannheim 3000
Roche Diagnostics, Penzberg 3000 + Biostack
University Freiburg, Immunology 3000
University Regensburg, Microbiology 2000
University Regensburg, Oncology/Heamatology
3000
LMU Genzentrum, Munich 5000-F gamma
University Munich, Dermatological Clinic 2000
University Tübingen, Dermatological Clinic 3000
University Homburg/Saar, Oncology 3000
Diabetes-Research Institute, Düsseldorf 3000
University Bonn 2000
University Bonn, Dermatological Clinic 2000
University Giessen/Marburg, Immunology 4000 Pro-B
University Essen, Immunology 2000
Sanofi Aventis, Frankfurt 4000 Pro-B-i
University Marburg, Virology 5000 Pro-S
MPI Berlin, Infection Biology 2000
Charité Berlin, Dermatological Clinic 3000
TU Dresden, CRTD/Biotec 5000 -X